Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: As patient advocates and advocacy groups emerge as pivotal players in promoting access to healthcare, we explore their role in promoting radionuclide therapy in NETs.
Conference:
Presenting Author: Dureja S
Authors: Dureja S,
Keywords: Neuroendocrine tumour, Patient Advocacy, PRRT, Theranostics, Developing countries,
Introduction: General population interest in neuroendocrine tumors (NET) is influenced by mass-media news and awareness campaigns by advocacy and medical groups. Cases of NET in famous people greatly impact conversations about this disease.
Conference:
Presenting Author:
Authors: Hernando Cubero J, Garcia Alvarez A, Roca-Herrera M, Carmona Alonso A, Garcia Burillo A,
Introduction: Quality of life is very important in patients with neuroendocrine tumors (NET), but other aspects such as satisfaction and empowerment of patients have been less studied. In Spain, there is a lack of validated cancer empowerment questionnaires.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author: Hernando J
Authors: Hernando J, Sampedro-Núñez M, Muñoz de Nova J, Triviño E, Vázquez G,
Keywords: empowerment, online survey, patient advocacy,
Introduction: The use of Twitter to disseminate medical content has increased over the last decade. Although Twitter activity by oncologists is clustered around international conferences, advocacy groups have different temporal social media patterns. Furthermore, given the non-standardized method of indexing tweets using Twitter hashtags, it can be difficult to follow the full breadth of a topic.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Keywords: Neuroendocrine Tumor, Social Media, Twitter, Advocacy,
Introduction: NETs are associated with a range of symptoms, and symptom reduction is a common treatment target. Identifying priority symptoms across NETs can help inform clinical trial endpoints.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Kaiser K, Webster K, Shaunfield S, Greene G, Yount S,
Keywords: neuroendocrine tumors, priority symptoms, qualitative methods,